An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
Ann & Robert H Lurie Children's Hospital of Chicago
40 participants
Sep 28, 2020
INTERVENTIONAL
Conditions
Summary
The primary objective of this study is to evaluate a potential behavioral intervention (MED-Go app). To meet this objective, the researchers will conduct a pilot randomized controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to promote medication adherence behavior and improve health outcomes in AYA with SCD.
Eligibility
Inclusion Criteria4
- Age 12-21 years old
- Any sickle cell disease genotype
- On steady state of hydroxyurea for 2 months
- Own of have access to a smartphone during the study period
Exclusion Criteria1
- Recent hospitalizations within the past 7 days
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A novel multifunctional mobile app (MED-Go) to improve adherence to hydroxyurea in patients with sickle cell disease
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04688411